Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Vaccine Effectiveness × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 159 Neoplasms 127 Carcinoma, Non-Small-Cell Lung 90 Colorectal Neoplasms 80 Prostatic Neoplasms 76 Lung Neoplasms 74 Leukemia, Myeloid, Acute 48 Carcinoma, Hepatocellular 46 Multiple Myeloma 44 Squamous Cell Carcinoma of Head and Neck 43 Neoplasm Metastasis 40 Glioblastoma 35 Pancreatic Neoplasms 34 Recurrence 33 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Brain Neoplasms 33 Ovarian Neoplasms 32 Triple Negative Breast Neoplasms 29 Glioma 28 Uterine Cervical Neoplasms 27 Stomach Neoplasms 27 Rectal Neoplasms 26 Melanoma 26 Endometrial Neoplasms 26 Colonic Neoplasms 25 Small Cell Lung Carcinoma 23 Head and Neck Neoplasms 23 Motor Activity 21 Anxiety Disorders 20 Sarcoma 19

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡